News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,031 Results
Type
Article (39068)
Company Profile (279)
Press Release (646684)
Section
Business (203871)
Career Advice (1991)
Deals (35364)
Drug Delivery (86)
Drug Development (80809)
Employer Resources (168)
FDA (16090)
Job Trends (14805)
News (344563)
Policy (32440)
Tag
Academia (2530)
Alliances (49097)
Alzheimer's disease (1236)
Approvals (16025)
Artificial intelligence (134)
Bankruptcy (352)
Best Places to Work (11544)
Biotechnology (200)
Breast cancer (132)
Cancer (1126)
Cardiovascular disease (102)
Career advice (1660)
Cell therapy (238)
Clinical research (64304)
Collaboration (399)
Compensation (202)
COVID-19 (2532)
C-suite (97)
Data (1153)
Diabetes (154)
Diagnostics (6145)
Earnings (84839)
Employer resources (146)
Events (109652)
Executive appointments (320)
FDA (16646)
Funding (364)
Gene therapy (178)
GLP-1 (580)
Government (4327)
Healthcare (18681)
Infectious disease (2617)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16306)
Job creations (3624)
Job search strategy (1417)
Layoffs (413)
Legal (7854)
Lung cancer (172)
Manufacturing (178)
Medical device (13179)
Medtech (13184)
Mergers & acquisitions (19147)
Metabolic disorders (407)
Neuroscience (1518)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1514)
Obesity (234)
Opinion (179)
Patents (106)
People (56295)
Phase I (19970)
Phase II (28325)
Phase III (21120)
Pipeline (469)
Postmarket research (2554)
Preclinical (8501)
Radiopharmaceuticals (236)
Rare diseases (225)
Real estate (5890)
Regulatory (21544)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1320)
Startups (3562)
United States (13782)
Vaccines (551)
Weight loss (169)
Date
Today (26)
Last 7 days (464)
Last 30 days (3491)
Last 365 days (35604)
2024 (33138)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (193)
Asia (37152)
Australia (6064)
California (3401)
Canada (1319)
China (259)
Colorado (150)
Connecticut (158)
Europe (79545)
Florida (474)
Georgia (121)
Illinois (347)
Indiana (198)
Kansas (96)
Maryland (586)
Massachusetts (2673)
Michigan (160)
Minnesota (276)
New Jersey (977)
New York (983)
North Carolina (712)
Northern California (1514)
Ohio (139)
Pennsylvania (859)
South America (1091)
Southern California (1320)
Texas (491)
Utah (91)
Washington State (368)
686,031 Results for "namocell inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
Bio-Techne Corporation (NASDAQ:TECH), today announced it has completed the acquisition of Namocell, Inc.
July 5, 2022
·
2 min read
Deals
BIO-TECHNE TO ACQUIRE NAMOCELL
Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Namocell, Inc.
June 22, 2022
·
4 min read
BioMidwest
NAMOCELL HIGHLIGHTED IN NATURE PUBLICATION FOR EFFICIENT SINGLE CELL CLONING OF HUMAN PLURIPOTENT STEM CELLS
Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of a single-cell cloning workflow study using the Namocell ™ Single Cell Dispenser in Nature Protocols: Efficient and safe single-cell cloning of human pluripotent stem cells using the chroman 1, emricasan, polyamines, and trans-ISRIB (CEPT) cocktail.
November 17, 2022
·
3 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
WW International, Inc. Announces CFO Transition
November 27, 2024
·
4 min read
Press Releases
Immunic, Inc. to Participate in Investor Conference in December
November 26, 2024
·
5 min read
Press Releases
Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics
November 25, 2024
·
5 min read
Press Releases
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
November 28, 2024
·
3 min read
1 of 68,604
Next
